ACRX Forecast and Technical Stock AnalysisSell candidate since 2019-07-19
AcelRx Pharmaceuticals fell by -3.20% in the last day ( Friday, 19th Jul 2019 ) from $2.81 to $2.72 and has now fallen 3 days in a row. During day the stock fluctuated 3.51% from a day low at $2.71 to a day high of $2.80. The price has fallen in 5 of the last 10 days , but is still up by 11.02% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -47 446 shares and in total 937 684 shares bought and sold for approximately $2.55 million.
- 30 day high of the ACRX stock price was $3.02 and low was $2.02.
- 90 day high was $4.00 and low was $2.02.
- 52 week high for the AcelRx Pharmaceuticals - $5.05 and low - $1.99.
AcelRx Pharmaceuticals lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $2.74 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -31.66% during the next 3 months and, with 90% probability hold a price between $1.14 and $1.87 at the end of this period.
AcelRx Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $2.79. On a fall, the stock will find some support from the long-term average at approximately $2.49. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Wednesday July 10, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 59 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $2.53 and $2.45.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AcelRx Pharmaceuticals finds support just below today's level at $2.53. If this is broken, then the next support from accumulated volume will be at $2.45 and $2.42.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.09 between high and low, or 3.51%. For the last week, the stock has had a daily average volatility of 4.67%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
4.67 %Average volatility
Very Low Low Medium High Very High
AcelRx Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|ACRX $2.72 ($-0.09 -3.20%)|
ACRX is down $0.09 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACRX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACRX analysis is free »
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now